Dialyse aktuell, Table of Contents Dialyse aktuell 2014; 18(01): 48-49DOI: 10.1055/s-0034-1366969 Forum der Industrie Georg Thieme Verlag KG Stuttgart · New York Entwicklung von neuen Phosphatbindern – Das Ziel: effektive Therapie bei niedriger Tablettenlast Recommend Article Abstract Full Text References Literatur 1 Chiu YW, Teitelbaum I, Misra M et al. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol 2009; 4: 1089-1096 2 Biotrends Treatment Trends Q3/2010 3 Fernández-Martín JL, Carrero JJ, Benedik M et al. COSMOS: the dialysis scenario of CKD-MBD in Europe. Nephrol Dial Transplant 2013; 28: 1922-1935 4 Jamal SA, Vandermeer B, Raggi P et al. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 2013; 382: 1268-1277 5 Wüthrich RP, Chonchol M, Covic A et al. Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients. Clin J Am Soc Nephrol 2013; 8: 280-289 6 Floege J et al. ASN-Kongress 2012
